These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
505 related articles for article (PubMed ID: 27079889)
21. Arrhythmic episodes in patients implanted with a cardioverter-defibrillator - results from the Prospective Study on Predictive Quality with Preferencing PainFree ATP therapies (4P). Regoli F; Graf D; Schaer B; Duru F; Ammann P; Stefano LMDS; Naegli B; Burri H; Zbinden R; Krasniqi N; Fromer M; BMC Cardiovasc Disord; 2019 Jun; 19(1):146. PubMed ID: 31208342 [TBL] [Abstract][Full Text] [Related]
22. Sex Differences in Inappropriate ICD Device Therapies: MADIT-II and MADIT-CRT. Tompkins CM; McNitt S; Polonsky B; Daubert JP; Wang PJ; Moss AJ; Zareba W; Kutyifa V J Cardiovasc Electrophysiol; 2017 Jan; 28(1):94-102. PubMed ID: 27696593 [TBL] [Abstract][Full Text] [Related]
23. Propensity score matched comparison of subcutaneous and transvenous implantable cardioverter-defibrillator therapy in the SIMPLE and EFFORTLESS studies. Brouwer TF; Knops RE; Kutyifa V; Barr C; Mondésert B; Boersma LVA; Lambiase PD; Wold N; Jones PW; Healey JS Europace; 2018 Sep; 20(FI2):f240-f248. PubMed ID: 29771327 [TBL] [Abstract][Full Text] [Related]
24. Incidence of and predictors for appropriate implantable cardioverter-defibrillator therapy in patients with a secondary preventive implantable cardioverter-defibrillator indication. Schaer B; Kühne M; Reichlin T; Osswald S; Sticherling C Europace; 2016 Feb; 18(2):227-31. PubMed ID: 26063686 [TBL] [Abstract][Full Text] [Related]
25. Prolonged sustained ventricular fibrillation in a patient with dextrocardia and a left ventricular assist device. Bolzan B; Morani G; Tomei R; Tomasi L; Borio G; Ribichini FL J Cardiovasc Med (Hagerstown); 2019 Oct; 20(10):721-724. PubMed ID: 31389822 [No Abstract] [Full Text] [Related]
26. Impact of programming strategies aimed at reducing nonessential implantable cardioverter defibrillator therapies on mortality: a systematic review and meta-analysis. Tan VH; Wilton SB; Kuriachan V; Sumner GL; Exner DV Circ Arrhythm Electrophysiol; 2014 Feb; 7(1):164-70. PubMed ID: 24446023 [TBL] [Abstract][Full Text] [Related]
27. Prevention of Sudden Cardiac Death: Focus on the Subcutaneous Implantable Cardioverter-Defibrillator. Adduci C; Palano F; Silvetti G; Cosentino P; Francia P High Blood Press Cardiovasc Prev; 2020 Aug; 27(4):291-297. PubMed ID: 32519207 [TBL] [Abstract][Full Text] [Related]
28. The subcutaneous implantable cardioverter defibrillator in 2019 and beyond. van Dijk VF; Boersma LV Trends Cardiovasc Med; 2020 Aug; 30(6):378-384. PubMed ID: 31610949 [TBL] [Abstract][Full Text] [Related]
29. Implantable Cardioverter Defibrillator Programming Characteristics, Shocked Rhythms, and Survival Among Patients Under Thirty Years of Age. Chang PM; Powell BD; Jones PW; Carter N; Hayes DL; Saxon LA J Cardiovasc Electrophysiol; 2016 Oct; 27(10):1183-1190. PubMed ID: 27334356 [TBL] [Abstract][Full Text] [Related]
30. Implantable cardioverter defibrillator therapy in paediatric practice: a single-centre UK experience with focus on subcutaneous defibrillation. Griksaitis MJ; Rosengarten JA; Gnanapragasam JP; Haw MP; Morgan JM Europace; 2013 Apr; 15(4):523-30. PubMed ID: 23333943 [TBL] [Abstract][Full Text] [Related]